Skip to main content
Fig. 5 | Respiratory Research

Fig. 5

From: Once-daily single-inhaler versus twice-daily multiple-inhaler triple therapy in patients with COPD: lung function and health status results from two replicate randomized controlled trials

Fig. 5

Change from baseline in serial FEV1 at Week 12 (ITT population). a. Study 207608; b. Study 207609; c. Pooled analysis. BUD, budesonide; CI, confidence interval; FEV1, forced expiratory volume in 1 s; FF, fluticasone furoate; FOR, formoterol; ITT, intent-to-treat; LS, least squares; TIO, tiotropium; UMEC, umeclidinium; VI, vilanterol.

Back to article page